Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice

Irene Sáez-Torres, Pablo Díaz-Villoslada, Eva Martínez-Cáceres, Isidro Ferrer, Xavier Montalban

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Abstract

We have studied the ability of gangliosides to induce or ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rat and SJL mice. None of the animals immunized with gangliosides with or without methylated bovine serum albumin (MBSA) developed EAE. Gangliosides were also administered simultaneously with PLP, but they did not alter the incidence or severity of EAE. However, high doses of MBSA could ameliorate or prevent EAE in a dose-dependent manner. T-cell responses towards gangliosides and antiganglioside antibodies were also studied. In conclusion, in these experimental models gangliosides have no encephalitogenic activity and do not alter the course of EAE.
Original languageEnglish
Pages (from-to)24-29
JournalJournal of Neuroimmunology
Volume84
Issue number1
DOIs
Publication statusPublished - 1 Apr 1998

Keywords

  • Experimental autoimmune encephalomyelitis
  • Gangliosides
  • Lewis rat
  • Methylated bovine serum albumin
  • SJL mouse

Fingerprint

Dive into the research topics of 'Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice'. Together they form a unique fingerprint.

Cite this